The Latin America, Middle East and Africa Insulin Syringes Market would witness market growth of 8.1% CAGR during the forecast period (2021-2027).
The insulin dosage determines the appropriate syringe size for individuals. One may need various syringe sizes to modify your insulin dose as needed because the insulin dose may alter based on the blood sugar levels. Insulin needles are available in a variety of diameters and thicknesses.
The length of a needle controls how far it can penetrate your skin. Insulin needles should only penetrate just beneath the skin, not into muscle. Shorter needles are less likely to penetrate the muscle. Insulin is administered subcutaneously, or beneath the skin, into the fat layer. A short needle is utilized to inject insulin into the fatty layer between the muscle and skin in this sort of injection.
Obesity rates among children and adolescents in Gulf countries range from 5% to 14% for men and 3% to 18% for girls. Obesity is on the rise in the Gulf area, with prevalence rates ranging from 2 percent to 55 percent in adult females and 1 percent to 30 percent in adult males. Obesity in the UAE is twice as high as the worldwide norm; in Kuwait, more than half of the adult population has diabetes connected to obesity, and 75 percent of Egyptians are overweight; medical experts blame the desert environment.
The Brazil market dominated the LAMEA Insulin Syringes Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $44.5 million by 2027. The Argentina market would exhibit a CAGR of 8.6% during (2021 - 2027). Additionally, The UAE market is poised to grow a CAGR of 7.8% during (2021 - 2027).
Based on Disease, the market is segmented into Type 2 Diabetes and Type 1 Diabetes. Based on Syringe Size, the market is segmented into 3/10 CC Syringe (0.3ml), 1/2 CC Syringe (0.5ml), 1CC Syringe (1ml) and Others. Based on End User, the market is segmented into Hospitals & Clinics, Homecare Settings, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Insulin Syringes Market is Predict to reach $2.1 Billion by 2027, at a CAGR of 4.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hindustan Syringes & Medical Devices Ltd., Novo Nordisk A/S, Biocon Limited, Eli Lilly and Company, Abbott Laboratories, Becton, Dickinson and Company, Cardinal Health, Inc., Medline Industries, Inc., Terumo Corporation, and Nipro Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Disease
- Type 2 Diabetes and
- Type 1 Diabetes
By Syringe Size
- 3/10 CC Syringe (0.3ml)
- 1/2 CC Syringe (0.5ml)
- 1CC Syringe (1ml) and
- Others
By End User
- Hospitals & Clinics
- Homecare Settings, and
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Hindustan Syringes & Medical Devices Ltd.
- Novo Nordisk A/S
- Biocon Limited
- Eli Lilly and Company
- Abbott Laboratories
- Becton, Dickinson and Company
- Cardinal Health, Inc.
- Medline Industries, Inc.
- Terumo Corporation
- Nipro Corporation
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Insulin Syringes Market, by Disease
1.4.2 LAMEA Insulin Syringes Market, by Syringe Size
1.4.3 LAMEA Insulin Syringes Market, by End User
1.4.4 LAMEA Insulin Syringes Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Insulin Syringes Market by Disease
3.1 LAMEA Type 2 Diabetes Market by Country
3.2 LAMEA Type 1 Diabetes Market by Country
Chapter 4. LAMEA Insulin Syringes Market by Syringe Size
4.1 LAMEA 3/10 CC Syringe (0.3ml) Market by Country
4.2 LAMEA 1/2 CC Syringe (0.5ml) Market by Country
4.3 LAMEA 1CC Syringe (1ml) Market by Country
4.4 LAMEA Other Syringe Size Market by Country
Chapter 5. LAMEA Insulin Syringes Market by End User
5.1 LAMEA Hospitals & Clinics Market by Country
5.2 LAMEA Homecare Settings Market by Country
5.3 LAMEA Others Market by Country
Chapter 6. LAMEA Insulin Syringes Market by Country
6.1 Brazil Insulin Syringes Market
6.1.1 Brazil Insulin Syringes Market by Disease
6.1.2 Brazil Insulin Syringes Market by Syringe Size
6.1.3 Brazil Insulin Syringes Market by End User
6.2 Argentina Insulin Syringes Market
6.2.1 Argentina Insulin Syringes Market by Disease
6.2.2 Argentina Insulin Syringes Market by Syringe Size
6.2.3 Argentina Insulin Syringes Market by End User
6.3 UAE Insulin Syringes Market
6.3.1 UAE Insulin Syringes Market by Disease
6.3.2 UAE Insulin Syringes Market by Syringe Size
6.3.3 UAE Insulin Syringes Market by End User
6.4 Saudi Arabia Insulin Syringes Market
6.4.1 Saudi Arabia Insulin Syringes Market by Disease
6.4.2 Saudi Arabia Insulin Syringes Market by Syringe Size
6.4.3 Saudi Arabia Insulin Syringes Market by End User
6.5 South Africa Insulin Syringes Market
6.5.1 South Africa Insulin Syringes Market by Disease
6.5.2 South Africa Insulin Syringes Market by Syringe Size
6.5.3 South Africa Insulin Syringes Market by End User
6.6 Nigeria Insulin Syringes Market
6.6.1 Nigeria Insulin Syringes Market by Disease
6.6.2 Nigeria Insulin Syringes Market by Syringe Size
6.6.3 Nigeria Insulin Syringes Market by End User
6.7 Rest of LAMEA Insulin Syringes Market
6.7.1 Rest of LAMEA Insulin Syringes Market by Disease
6.7.2 Rest of LAMEA Insulin Syringes Market by Syringe Size
6.7.3 Rest of LAMEA Insulin Syringes Market by End User
Chapter 7. Company Profiles
7.1 Hindustan Syringes & Medical Devices Ltd.
7.1.1 Company Overview
7.2 Novo Nordisk A/S
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental & Regional Analysis
7.2.4 Research & Development Expenses
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisitions and Mergers:
7.3 Biocon Limited
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.4 Eli Lilly and Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent Strategies and Developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Product Launches and Product Expansions:
7.4.5.3 Approvals and Trials:
7.5 Abbott Laboratories
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.6 Becton, Dickinson and Company
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Approvals and Trials:
7.9 Terumo Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental Analysis
7.10. Nipro Corporation
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
TABLE 1 LAMEA Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 2 LAMEA Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 3 LAMEA Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 4 LAMEA Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 5 LAMEA Type 2 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 6 LAMEA Type 2 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 7 LAMEA Type 1 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 8 LAMEA Type 1 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 9 LAMEA Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 10 LAMEA Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 11 LAMEA 3/10 CC Syringe (0.3ml) Market by Country, 2017 - 2020, USD Million
TABLE 12 LAMEA 3/10 CC Syringe (0.3ml) Market by Country, 2021 - 2027, USD Million
TABLE 13 LAMEA 1/2 CC Syringe (0.5ml) Market by Country, 2017 - 2020, USD Million
TABLE 14 LAMEA 1/2 CC Syringe (0.5ml) Market by Country, 2021 - 2027, USD Million
TABLE 15 LAMEA 1CC Syringe (1ml) Market by Country, 2017 - 2020, USD Million
TABLE 16 LAMEA 1CC Syringe (1ml) Market by Country, 2021 - 2027, USD Million
TABLE 17 LAMEA Other Syringe Size Market by Country, 2017 - 2020, USD Million
TABLE 18 LAMEA Other Syringe Size Market by Country, 2021 - 2027, USD Million
TABLE 19 LAMEA Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 20 LAMEA Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 21 LAMEA Hospitals & Clinics Market by Country, 2017 - 2020, USD Million
TABLE 22 LAMEA Hospitals & Clinics Market by Country, 2021 - 2027, USD Million
TABLE 23 LAMEA Homecare Settings Market by Country, 2017 - 2020, USD Million
TABLE 24 LAMEA Homecare Settings Market by Country, 2021 - 2027, USD Million
TABLE 25 LAMEA Others Market by Country, 2017 - 2020, USD Million
TABLE 26 LAMEA Others Market by Country, 2021 - 2027, USD Million
TABLE 27 LAMEA Insulin Syringes Market by Country, 2017 - 2020, USD Million
TABLE 28 LAMEA Insulin Syringes Market by Country, 2021 - 2027, USD Million
TABLE 29 Brazil Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 30 Brazil Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 31 Brazil Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 32 Brazil Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 33 Brazil Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 34 Brazil Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 35 Brazil Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 36 Brazil Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 37 Argentina Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 38 Argentina Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 39 Argentina Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 40 Argentina Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 41 Argentina Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 42 Argentina Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 43 Argentina Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 44 Argentina Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 45 UAE Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 46 UAE Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 47 UAE Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 48 UAE Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 49 UAE Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 50 UAE Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 51 UAE Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 52 UAE Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 53 Saudi Arabia Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 54 Saudi Arabia Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 55 Saudi Arabia Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 56 Saudi Arabia Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 57 Saudi Arabia Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 58 Saudi Arabia Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 59 Saudi Arabia Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 60 Saudi Arabia Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 61 South Africa Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 62 South Africa Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 63 South Africa Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 64 South Africa Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 65 South Africa Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 66 South Africa Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 67 South Africa Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 68 South Africa Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 69 Nigeria Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 70 Nigeria Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 71 Nigeria Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 72 Nigeria Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 73 Nigeria Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 74 Nigeria Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 75 Nigeria Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 76 Nigeria Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 77 Rest of LAMEA Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 78 Rest of LAMEA Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 79 Rest of LAMEA Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 80 Rest of LAMEA Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 81 Rest of LAMEA Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 82 Rest of LAMEA Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 83 Rest of LAMEA Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 84 Rest of LAMEA Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 85 Key Information – Hindustan Syringes & Medical Devices Ltd.
TABLE 86 Key information – Novo Nordisk A/S
TABLE 87 Key Information – Biocon Limited
TABLE 88 Key Information – Eli Lilly and Company
TABLE 89 Key Information – Abbott Laboratories
TABLE 90 Key information – Becton, Dickinson and Company
TABLE 91 key information – Cardinal Health, Inc.
TABLE 92 Key Information – Medline Industries, Inc.
TABLE 93 Key Information – Terumo Corporation
TABLE 94 Key Information – Nipro Corporation
List of Figures
FIG 1 Methodology for the research